Unknown

Dataset Information

0

Paclitaxel Potentiates the Anticancer Effect of Cetuximab by Enhancing Antibody-Dependent Cellular Cytotoxicity on Oral Squamous Cell Carcinoma Cells In Vitro.


ABSTRACT: Administration of cetuximab (C-mab) in combination with paclitaxel (PTX) has been used for patients with head and neck squamous cell carcinoma (SCC) clinically. In this study, we attempted to clarify the molecular mechanisms of the enhancing anticancer effect of C-mab combined with PTX on oral SCC cells in vitro. We used two oral SCC cells (HSC4, OSC19) and A431 cells. PTX alone inhibited cell growth in all cells in a concentration-dependent manner. C-mab alone inhibited the growth of A431 and OSC19 cells at low concentrations, but inhibited the growth of HSC4 cells very weakly, even at high concentrations. A combined effect of the two drugs was moderate on A431 cells, but slight on HSC4 and OSC19 cells. A low concentration of PTX enhanced the antibody-dependent cellular cytotoxicity (ADCC) induced by C-mab in all of the cells tested. PTX slightly enhanced the anticancer effect of C-mab in this ADCC model on A431 and HSC4 cells, and markedly enhanced the anticancer effect of C-mab on OSC19 cells. These results indicated that PTX potentiated the anticancer effect of C-mab through enhancing the ADCC in oral SCC cells.

SUBMITTER: Sawatani Y 

PROVIDER: S-EPMC7503545 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Paclitaxel Potentiates the Anticancer Effect of Cetuximab by Enhancing Antibody-Dependent Cellular Cytotoxicity on Oral Squamous Cell Carcinoma Cells In Vitro.

Sawatani Yuta Y   Komiyama Yuske Y   Nakashiro Koh-Ichi KI   Uchida Daisuke D   Fukumoto Chonji C   Shimura Michiko M   Hasegawa Tomonori T   Kamimura Ryouta R   Hitomi-Koide Masayo M   Hyodo Toshiki T   Kawamata Hitoshi H  

International journal of molecular sciences 20200831 17


Administration of cetuximab (C-mab) in combination with paclitaxel (PTX) has been used for patients with head and neck squamous cell carcinoma (SCC) clinically. In this study, we attempted to clarify the molecular mechanisms of the enhancing anticancer effect of C-mab combined with PTX on oral SCC cells in vitro. We used two oral SCC cells (HSC4, OSC19) and A431 cells. PTX alone inhibited cell growth in all cells in a concentration-dependent manner. C-mab alone inhibited the growth of A431 and O  ...[more]

Similar Datasets

| S-EPMC4681575 | biostudies-literature
| S-EPMC2410169 | biostudies-other
| S-EPMC5976479 | biostudies-literature
| S-EPMC7068343 | biostudies-literature
| S-EPMC5749662 | biostudies-literature
| S-EPMC4891046 | biostudies-literature
| S-EPMC8214220 | biostudies-literature
| S-EPMC9712204 | biostudies-literature
| S-EPMC7954609 | biostudies-literature
| S-EPMC8429935 | biostudies-literature